Reduced intensity allogeneic hematopoietic stem cell transplantion for MDS using tacrolimus/sirolimus-based GVHD prophylaxis

We report a consecutive series of 59 patients with MDS who underwent reduced-intensity hematopoietic stem cell transplantation (RI-HSCT) with fludarabine/melphalan conditioning and tacrolimus/sirolimus-based GVHD prophylaxis. Two-year OS, EFS, and relapse incidences were 75.1%, 65.2%, and 20.9%, res...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Nakamura, Ryotaro, Palmer, Joycelynne M., O'Donnell, Margaret R., Stiller, Tracey, Thomas, Sandra H., Chao, Joseph, Alvarnas, Joseph, Parker, Pablo M., Pullarkat, Vinod, Maegawa, Rodrigo, Stein, Anthony S., Snyder, David S., Bhatia, Ravi, Chang, Karen, Wang, Shirong, Cai, Ji-Lian, Senitzer, David, Forman, Stephen J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2012
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3433241/
https://ncbi.nlm.nih.gov/pubmed/22677229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2012.04.022
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items